Rapid Autopsy Protocol for Patients with Small Cell Lung Cancer
Recruiting at 2 trial locations
AK
SI
TH
DR
GK
Overseen ByGabby Kline, BA
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Indiana University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Trial Summary
What is the purpose of this trial?
This is pilot study to establish a rapid autopsy program in Small Cell Lung Cancer (SCLC) at the Indiana University Simon Comprehensive Cancer Center and outline the components necessary for tumor tissue collection.
Research Team
SI
Shadia I. Jalal, MD
Principal Investigator
Indiana University
Eligibility Criteria
Inclusion Criteria
≥ 18 years old at the time of informed consent
Written informed consent and HIPAA authorization for release of personal health information.
Active SCLC diagnosis
Treatment Details
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Active SCLC DiagnosisExperimental Treatment1 Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
Trials
1,063
Recruited
1,182,000+
Other People Viewed
By Subject
By Trial
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.